Cervical cancer natural history, complications and prognosis: Difference between revisions
(Created page with "{{Cervical cancer}} {{CMG}} ==Overview== Prognosis depends on the stage of the cancer. With treatment, 80 to 90% of women with stage I cancer and 50 to 65% of those with stag...") |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Cervical cancer}} | {{Cervical cancer}} | ||
{{CMG}} | {{CMG}} |
Revision as of 13:10, 11 September 2012
Cervical cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cervical cancer natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Cervical cancer natural history, complications and prognosis |
FDA on Cervical cancer natural history, complications and prognosis |
CDC on Cervical cancer natural history, complications and prognosis |
Cervical cancer natural history, complications and prognosis in the news |
Blogs on Cervical cancer natural history, complications and prognosis |
Risk calculators and risk factors for Cervical cancer natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Prognosis depends on the stage of the cancer. With treatment, 80 to 90% of women with stage I cancer and 50 to 65% of those with stage II cancer are alive 5 years after diagnosis. Only 25 to 35% of women with stage III cancer and 15% or fewer of those with stage IV cancer are alive after 5 years.
Prognosis
According to the International Federation of Gynecology and Obstetrics, survival improves when radiotherapy is combined with cisplatin-based chemotherapy.[1]
As the cancer metastasizes to other parts of the body, prognosis drops dramatically because treatment of local lesions is generally more effective than whole body treatments such as chemotherapy.
Interval evaluation of the patient after therapy is imperative. Recurrent cervical cancer detected at its earliest stages might be successfully treated with surgery, radiation, chemotherapy, or a combination of the three. Thirty-five percent of patients with invasive cervical cancer have persistent or recurrent disease after treatment.[2]
Average years of potential life lost from cervical cancer are 25.3 (SEER Cancer Statistics Review 1975-2000, National Cancer Institute (NCI)). Approximately 4,600 women were projected to die in 2001 in the US of cervical cancer (DSTD), and the annual incidence was 13,000 in 2002 in the US, as calculated by SEER. Thus the ratio of deaths to incidence is approximatley 35.4%.
Regular screening has meant that pre cancerous changes and early stage cervical cancers have been detected and treated early. Figures suggest that cervical screening is saving 5,000 lives each year in the UK by preventing cervical cancer.[3]
References
- ↑ Committee on Practice Bulletins-Gynecology (2002). "ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas, number 35, May 2002". Obstetrics and gynecology. 99 (5 Pt 1): 855–67. PMID 11978302.
- ↑ "Cervical Cancer". Cervical Cancer: Pathology, Symptoms and Signs, Diagnosis, Prognosis and Treatment. Armenian Health Network, Health.am.
- ↑ "Cervical cancer statistics and prognosis". Cancer Research UK. Retrieved 2007-03-24.